Hollow fiber membrane contactor as a gas-liquid model contactor

Microporous hollow fiber gas-liquid membrane contactors have a fixed and well-defined gas-liquid interfacial area. The liquid flow through the hollow fiber is laminar, thus the liquid side hydrodynamics are well known. This allows the accurate calculation of the fiber side physical mass transfer coefficient from first principles. Moreover, in the case of gas-liquid membrane contactor, the gas-liquid exposure time can be varied easily and independently without disturbing the gas-liquid interfacial area. These features of the hollow fiber membrane contactor make it very suitable as a gas-liquid model contactor and offer numerous advantages over the conventional model contactors. The applicability and the limitations of this novel model contactor for the determination of physico-chemical properties of non-reactive and reactive gas-liquid systems are investigated in the present work. Absorption of CO 2 into water and into aqueous NaOH solutions are chosen as model systems to determine the physico-chemical properties for non-reactive and reactive conditions, respectively. The experimental findings for these systems show that a hollow fiber membrane contactor can be used successfully as a model contactor for the determination of various gas-liquid physico-chemical properties. Moreover, since the membrane contactor facilitates indirect contact between the two phases, the application of hollow fiber model contactor can possibly be extended to liquid-liquid systems and/or heterogeneous catalyzed gas-liquid systems

Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study

Peer reviewe

Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

Ristola M. on työryhmien DAD Study Grp ; Royal Free Hosp Clin Cohort ; INSIGHT Study Grp ; SMART Study Grp ; ESPRIT Study Grp jäsen.Background Chronic kidney disease (CKD) is a major health issue for HIV-positive individuals, associated with increased morbidity and mortality. Development and implementation of a risk score model for CKD would allow comparison of the risks and benefits of adding potentially nephrotoxic antiretrovirals to a treatment regimen and would identify those at greatest risk of CKD. The aims of this study were to develop a simple, externally validated, and widely applicable long-term risk score model for CKD in HIV-positive individuals that can guide decision making in clinical practice. Methods and Findings A total of 17,954 HIV-positive individuals from the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study with >= 3 estimated glomerular filtration rate (eGFR) values after 1 January 2004 were included. Baseline was defined as the first eGFR > 60 ml/min/1.73 m2 after 1 January 2004; individuals with exposure to tenofovir, atazanavir, atazanavir/ritonavir, lopinavir/ritonavir, other boosted protease inhibitors before baseline were excluded. CKD was defined as confirmed (>3 mo apart) eGFR In the D:A:D study, 641 individuals developed CKD during 103,185 person-years of follow-up (PYFU; incidence 6.2/1,000 PYFU, 95% CI 5.7-6.7; median follow-up 6.1 y, range 0.3-9.1 y). Older age, intravenous drug use, hepatitis C coinfection, lower baseline eGFR, female gender, lower CD4 count nadir, hypertension, diabetes, and cardiovascular disease (CVD) predicted CKD. The adjusted incidence rate ratios of these nine categorical variables were scaled and summed to create the risk score. The median risk score at baseline was -2 (interquartile range -4 to 2). There was a 1: 393 chance of developing CKD in the next 5 y in the low risk group (risk score = 5, 505 events), respectively. Number needed to harm (NNTH) at 5 y when starting unboosted atazanavir or lopinavir/ritonavir among those with a low risk score was 1,702 (95% CI 1,166-3,367); NNTH was 202 (95% CI 159-278) and 21 (95% CI 19-23), respectively, for those with a medium and high risk score. NNTH was 739 (95% CI 506-1462), 88 (95% CI 69-121), and 9 (95% CI 8-10) for those with a low, medium, and high risk score, respectively, starting tenofovir, atazanavir/ritonavir, or another boosted protease inhibitor. The Royal Free Hospital Clinic Cohort included 2,548 individuals, of whom 94 individuals developed CKD (3.7%) during 18,376 PYFU (median follow-up 7.4 y, range 0.3-12.7 y). Of 2,013 individuals included from the SMART/ESPRIT control arms, 32 individuals developed CKD (1.6%) during 8,452 PYFU (median follow-up 4.1 y, range 0.6-8.1 y). External validation showed that the risk score predicted well in these cohorts. Limitations of this study included limited data on race and no information on proteinuria. Conclusions Both traditional and HIV-related risk factors were predictive of CKD. These factors were used to develop a risk score for CKD in HIV infection, externally validated, that has direct clinical relevance for patients and clinicians to weigh the benefits of certain antiretrovirals against the risk of CKD and to identify those at greatest risk of CKD.Peer reviewe

CO2 absorption in carbonate/bicarbonate solutions: The Danckwerts-criterion revisited

In industrial applications CO2 is frequently removed from gas streams at elevated pressures by absorption and subsequent chemical reaction in carbonate/bicarbonate solutions (e.g. Benfield process). The criterion that determines whether or not this reaction can be regarded as pseudo-first order is given by Danckwerts and Sharma (1966), but its derivation has never been published. In the present study, a consistent set of equations and physico-chemical parameters is presented to describe the CO2 absorption/reaction process. It was found that the criterion was justified, but should be somewhat confined to reduce possible errors. Furthermore, the model was validated by experiments in a stirred cell reactor up to CO2 partial pressures of 16 bar.

Renewable alkenes from the hydrothermal treatment of polyhydroxyalkanoates-containing sludge

Polyhydroxyalkanoates (PHA) are a key constituent of excess sludge produced by Aerobic Sewage Sludge Treatment plants. The accumulation of significant amount of PHA inside aerobic microbial cells occurs when a surplus of an easily degradable carbon source (e.g., volatile fatty acids, VFA) is found in combination with other nutrients limitation. Herein, hydrothermal treatment (HT) of PHA-containing sludge at 300 and 375 \ub0C was demonstrated to be effective in converting most (>70% w/w) of the bacterial PHA stored inside microbial cells into alkene/CO2 gas mixtures. Simultaneously, most of non-PHA biomass was converted into water-soluble compounds (50% carbon yield) that were acidogenic fermented to produce volatile fatty acids, ideal substrate to feed aerobic bacteria and produce more PHA. According to results here presented, HT of excess sludge with moderate (13%) PHA content can produce about 50 kg of alkenes per tonne of suspended solids treated, with a significant reduction of sludge mass (80% reduction of wet sludge volume) and consequent disposal cost